Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-01 Sale | 2024-08-05 6:57 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $4.4441 | $148,135 | 42,859 (Direct) | View |
2024-07-08 Sale | 2024-07-10 4:15 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $4.031 | $134,366 | 105,199 (Direct) | View |
2024-06-20 Sale | 2024-06-24 4:17 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $4.094 | $136,465 | 91,667 (Direct) | View |
2023-04-10 Sale | 2023-04-12 5:03 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 14,134 | $5 | $70,670 | 61,221 (Direct) | View |
2023-04-05 Sale | 2023-04-07 4:43 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 34,160 | $5.0239 | $171,616 | 83,197 (Direct) | View |
2023-03-31 Sale | 2023-04-04 7:00 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 9,973 | $5.022 | $50,084 | 201,118 (Direct) | View |
2023-02-01 Sale | 2023-02-03 4:32 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $5.7158 | $166,517 | 155,845 (Direct) | View |
2023-01-03 Sale | 2023-01-05 5:31 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $5.0819 | $148,051 | 35,491 (Direct) | View |
2022-12-02 Sale | 2022-12-06 5:31 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $5.8114 | $169,303 | 77,335 (Direct) | View |
2022-11-01 Sale | 2022-11-03 4:53 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $6.9224 | $201,670 | 65,172 (Direct) | View |
2022-10-10 Sale | 2022-10-12 4:09 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $6.4588 | $188,165 | 60,016 (Direct) | View |
2021-11-12 Sale | 2021-11-16 7:10 pm | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales | 125,105 | $12.31 | $1,540,079 | 284,678 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-01 Exercise | 2024-08-05 6:57 pm | N/A 2030-01-20 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $0 | 42,859 (Direct) | View |
2024-08-01 Exercise | 2024-08-05 6:57 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $1.641 | 42,859 (Direct) | View |
2024-07-08 Exercise | 2024-07-10 4:15 pm | N/A 2030-01-20 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $0 | 105,199 (Direct) | View |
2024-07-08 Exercise | 2024-07-10 4:15 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $1.641 | 105,199 (Direct) | View |
2024-06-20 Exercise | 2024-06-24 4:17 pm | N/A 2030-01-20 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $0 | 91,667 (Direct) | View |
2024-06-20 Exercise | 2024-06-24 4:17 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES | 33,333 | $1.641 | 91,667 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 6:21 pm | N/A 2034-03-14 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, GLOBAL SALES & MARKETING | 125,000 | $0 | 125,000 (Direct) | View |
2023-04-10 Exercise | 2023-04-12 5:03 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 14,134 | $2.142 | 61,221 (Direct) | View |
2023-04-10 Exercise | 2023-04-12 5:03 pm | N/A 2029-03-04 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 14,134 | $0 | 61,221 (Direct) | View |
2023-04-05 Exercise | 2023-04-07 4:43 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 34,160 | $2.142 | 83,197 (Direct) | View |
2023-04-05 Exercise | 2023-04-07 4:43 pm | N/A 2029-03-04 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 34,160 | $0 | 83,197 (Direct) | View |
2023-03-31 Exercise | 2023-04-04 7:00 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 9,973 | $2.142 | 201,118 (Direct) | View |
2023-03-31 Exercise | 2023-04-04 7:00 pm | N/A 2029-03-04 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 9,973 | $0 | 201,118 (Direct) | View |
2023-03-20 Option Award | 2023-03-21 4:42 pm | N/A 2033-03-19 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 120,000 | $0 | 120,000 (Direct) | View |
2023-02-01 Exercise | 2023-02-03 4:32 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 26,665 | $2.142 | 155,845 (Direct) | View |
2023-02-01 Exercise | 2023-02-03 4:32 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 2,468 | $0.983 | 155,845 (Direct) | View |
2023-02-01 Exercise | 2023-02-03 4:32 pm | N/A 2026-06-13 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $0 | 155,845 (Direct) | View |
2023-01-03 Exercise | 2023-01-05 5:31 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $0.983 | 35,491 (Direct) | View |
2023-01-03 Exercise | 2023-01-05 5:31 pm | N/A 2026-06-13 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $0 | 35,491 (Direct) | View |
2022-12-02 Exercise | 2022-12-06 5:31 pm | N/A 2026-06-13 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $0 | 77,335 (Direct) | View |
2022-12-02 Exercise | 2022-12-06 5:31 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $1.08 | 77,335 (Direct) | View |
2022-11-01 Exercise | 2022-11-03 4:53 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 27,867 | $0.84 | 65,172 (Direct) | View |
2022-11-01 Exercise | 2022-11-03 4:53 pm | N/A 2026-01-10 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $0 | 65,172 (Direct) | View |
2022-11-02 Exercise | 2022-11-03 4:53 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 1,266 | $1.08 | 65,172 (Direct) | View |
2022-10-10 Exercise | 2022-10-12 4:09 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $0.84 | 60,016 (Direct) | View |
2022-10-10 Exercise | 2022-10-12 4:09 pm | N/A 2026-01-10 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 29,133 | $0 | 60,016 (Direct) | View |
2022-03-25 Option Award | 2022-03-29 4:20 pm | N/A 2032-03-24 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales & Marketing | 142,000 | $0 | 142,000 (Direct) | View |
2021-11-12 Exercise | 2021-11-16 7:10 pm | N/A N/A | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales | 125,105 | $0.84 | 284,678 (Direct) | View |
2021-11-12 Exercise | 2021-11-16 7:10 pm | N/A 2026-01-10 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales | 125,105 | $0 | 284,678 (Direct) | View |
2021-08-09 Option Award | 2021-08-11 5:19 pm | N/A 2031-08-09 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2021-07-29 6:44 pm | N/A 2026-01-10 | MAXCYTE INC. | MXCT | Ross Thomas M. EVP, Global Sales | 0 | $0 | 692,905 (Direct) | View |